SA

Somnath Adduri

Director Director DIN 08563640
DIN 08563640 First appointment Sep 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Sep 2019
Shareholding value Locked Premium profile

About Somnath Adduri

Data last updated:

Somnath Adduri has 7 years in corporate governance. Formerly with 1 company, such as Iros Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08563640
Primary Designation Director
First Appointment 16 Sep 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Iros Pharma Private Limited U24299AP2019PTC112905
Director16 Sep 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Iros Pharma Private Limited
Premium access

Shareholding and investment profile for Somnath Adduri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Somnath Adduri

Somnath Adduri has 7 years in corporate governance. Formerly with 1 company, such as Iros Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Somnath Adduri is associated with 0 companies as a director.

Somnath Adduri has expertise in General Business.

Somnath Adduri has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available